comparemela.com

Latest Breaking News On - Gastrointestinal cancer research program - Page 1 : comparemela.com

To Attain Diversity in Clinical Trial Enrollment, It Takes a Village

Coverage from the session, "Bringing Health Equity to Clinical Trials at Every Step," at Patient-Centered Oncology Care 2023.

Texas
United-states
Tennessee
Alabama
Dallas
University-of-alabama-at-birmingham
South-carolina
Fort-worth
America
American
Alyssa-schatz
Amitkumar-mehta

EMERALD-1: Durvalumab and Bevacizumab Plus TACE Improves PFS in Patients With Unresectable HCC

One expert said the results have the potential to change the standard of care for some patients with the most common type of liver cancer.

Italy
California
United-states
San-francisco
Barcelona
Comunidad-autonoma-de-cataluna
Spain
American
Riccardo-lencioni
Cathy-eng
Division-of-hematology
Department-of-medicine

New treatment for metastatic colorectal cancer prolongs survival

A new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.

Japan
China
Cathy-eng
Davidh-johnson
European-medicines-agency
Medicine-at-vanderbilt-university-medical-center
Devices-agency
Drug-administration
Medical-oncology
Vanderbilt-university-medical-center
Gastrointestinal-cancer-research-program
Vanderbilt-ingram-cancer-center

Fruquintinib: Researchers reveal new treatment for metastatic colorectal cancer prolongs survival, ET HealthWorld

According to the findings of an international clinical study published in The Lancet, the selectively targeted medication Fruquintinib resulted in a statistically significant improvement in overall survival and progression-free survival.

Tennessee
United-states
China
Vanderbilt-university
Japan
Davidh-johnson
Cathy-eng
Drug-administration
Devices-agency
European-medicines-agency
Medicine-at-vanderbilt-university-medical-center
Medical-oncology

Researchers reveal new treatment for metastatic colorectal cancer prolongs survival

Tennessee, June 16: A new treatment option for people with metastatic colorectal cancer who have exhausted all other alternatives is on the horizon.

Tennessee
United-states
Jammu
Jammu-and-kashmir
India
Vanderbilt-university
China
Japan
Davidh-johnson
Cathy-eng
Drug-administration
European-medicines-agency

vimarsana © 2020. All Rights Reserved.